Dr. Michael Bauer, Chief Executive Officer

Dr. Michael Bauer

Chief Executive Officer
Board Member

Chief Executive Officer and Board member of Cellestia Biotech AG, Basel, Switzerland. Michael is a senior drug development professional with over 18 years’ experience in the life sciences industry. He served in senior leadership positions across disciplines such as clinical and preclinical drug development, project & portfolio management, regulatory affairs and metabolism research. He has many years of experience in leading global development projects, covering the full range of drug development, from early stage preclinical through Phase I, II and III clinical development, including IND and NDA submissions. Most recent assignments were with Novartis Pharma AG, Translational Medicine Oncology, working as Senior Global Program Manager Development and Polyphor Ltd., where he served as Head of Clinical Development. Under his leadership, several new oncology drugs were brought into clinical development and reached clinical proof of concept. Michael holds a Ph.D. in Biotechnology and M.Sc. in Chemistry. Linkedin Profile


2015 – today
Cellestia Biotech AG, Basel, Switzerland (& Lausanne, Switzerland)
Chief Executive Officer (CEO) & co-founder

2012 – 2016
Polyphor Ltd, Allschwil, Switzerland
Head of Development

2009 – 2012
Novartis Pharma AG, Basel, Switzerland
Senior Global Program Manager

2007 – 2009
Arpida Ltd, Reinach, Switzerland
Global Development Program Leader

2004 – 2007
Syngenta AG, Basel, Switzerland
Global Development Project & Portfolio Manager

2001 – 2004
Syngenta AG, Basel, Switzerland
Global Regulatory Affairs Manager

1997 – 2001
Zeneca plc, Bracknell, United Kingdom
Metabolism Chemist


1994 – 1997
PhD Thesis, Biotechnology at Technical University Hamburg-Harburg, Germany

1987 – 1994
MSc studies and thesis, Institute for Chemistry, University Hamburg, Germany